– February 1, 2011
February 1, 2011
View Issues
-
Current Approaches for Treating Patients with Fludarabine-resistant CLL
A 58-year-old retired school principal was seen in the office because of malaise and weight loss. He had been well until 4 years ago when he was discovered, at a routine annual exam, to have lymphocytosis. -
Hypereosinophilia: Current Classification and Treatment Approaches
With the development of an increased understanding of cellular biology, in general, and the regulation of eosinophils, in particular, the heterogeneous diagnosis of hypereosinophilic Syndrome (HES) has now been better defined and a classification system has been developed with clear clinical implications. -
Study Evaluates Autologous Transplant for Rare Myelomas
Very limited data are available on autologous transplant outcomes for uncommon or rare multiple myeloma (MM) subtypes. -
Cetuximab and First-cycle Rash: Correlation with NSCLC Outcomes
The occurrence of skin rash in patients receiving cetuximab is common, and for patients with colon cancer, this has been associated with better clinical outcomes. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Statins and liver function; dosing timing for thyroxine; rivaroxaban for VTE, DVT, and stroke; echinacea and the common cold; and FDA actions.